We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03541447
Recruitment Status : Completed
First Posted : May 30, 2018
Last Update Posted : March 11, 2022
Otsuka Pharmaceutical Italy S.r.l.
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 23, 2021
Actual Study Completion Date : December 23, 2021